Exploring the Basics of CRM in Stock Investing

By Tamara Parker • Wednesday, December 04 10:12 • Permanent Link

Salesforce logged a 9.0% change during today's morning session, and is now trading at a price of $361.17 per share. The S&P 500 index moved 0.0%. CRM's trading volume is 9,659,757 compared to the stock's average volume of 5,488,293.

Salesforce trades -2.08% away from its average analyst target price of $368.83 per share. The 45 analysts following the stock have set target prices ranging from $260.0 to $450.0, and on average have given Salesforce a rating of buy.

Anyone interested in buying CRM should be aware of the facts below:

Salesforce's current price is 377.3% above its Graham number of $75.67, which implies that at its current valuation it does not offer a margin of safety
Salesforce has moved 33.0% over the last year, and the S&P 500 logged a change of 33.0%
Based on its trailing earnings per share of 6.07, Salesforce has a trailing 12 month Price to Earnings (P/E) ratio of 59.5 while the S&P 500 average is 29.3
CRM has a forward P/E ratio of 32.5 based on its forward 12 month price to earnings (EPS) of $11.13 per share
Its Price to Book (P/B) ratio is 5.88 compared to its sector average of 3.91
Salesforce, Inc. provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide.
Based in San Francisco, the company has 72,682 full time employees and a market cap of $345.28 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.